One of our key tools is the assembloid model—a cutting-edge 3D culture system that mimics the complexity of human tumors by incorporating cancer cells with supporting stromal and immune components. This model enables us to test drug responses in a patient-specific context, offering a powerful platform for predicting treatment outcomes and guiding personalized therapeutic decisions.